Shortages Of Shingles Vaccine Due To High Demand.

The New York Times (9/25, Grady) reports that demand for the vaccine for shingles, Shingrix (zoster vaccine recombinant), is so high that its manufacturer, GlaxoSmithKline, has had difficulty producing enough to keep up with demand. The company “says the...